aTyr Pharma, Inc. (ATYR) vs MIRA Pharmaceuticals, Inc. (MIRA)

A side-by-side comparison of aTyr Pharma, Inc. and MIRA Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
aTyr Pharma, Inc. logo
ATYR
aTyr Pharma, Inc.
$28M
$0.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MIRA Pharmaceuticals, Inc. logo
MIRA
MIRA Pharmaceuticals, Inc.
$30M
$0.71HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ATYR vs MIRA

growth of $100 · dividends reinvested · last 2y
ATYR -83.2% (-59.1%/yr)MIRA -10.1% (-5.2%/yr)MIRA compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$17$90
ATYR MIRA

ATYR vs MIRA: by the numbers

  • •MIRA is the larger company ($30M vs $28M market cap).
  • •Both run net losses; MIRA's is the smaller (0.00% vs -32003.68% net margin).

Metrics side by side

Valuation

MetricATYRMIRA
P/S ratio146.25N/A
P/B ratio0.573.66

Profitability

MetricATYRMIRA
Gross margin-717.37%0.00%
Operating margin-40856.32%0.00%
Net margin-32003.68%0.00%
ROE-124.64%-116.14%
ROIC-109.29%-115.18%

Growth (annualized)

MetricATYRMIRA
Revenue CAGR (5Y)-38.74%N/A

Go deeper

Full ATYR analysisFull MIRA analysisInteractive comparison tool

Dig into the metrics

aTyr Pharma ROEMIRA Pharmaceuticals ROEaTyr Pharma operating marginMIRA Pharmaceuticals operating marginaTyr Pharma revenue growthMIRA Pharmaceuticals revenue growthaTyr Pharma free cash flowMIRA Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.